1-9 of 9
Roch Houot
Close
Sort by
Journal Articles

Impact of diagnostic investigations in the management of CAR T-cell–associated neurotoxicity

Clinical Trials & Observations
Matteo Mauget, Sophie Lemercier, Quentin Quelven, Adel Maamar, Faustine Lhomme, Sophie De Guibert, Roch Houot, Guillaume Manson
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2491–2498.
https://doi.org/10.1182/bloodadvances.2023011669
Published: 2024
Includes: Supplemental data
Journal Articles

Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)

Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne, Franck Morschhauser, Fabien Le Bras, Kamal Bouabdallah, Fabien Despas, Jacques-Olivier Bay, Marie-Thérèse Rubio, Mohamad Mohty, Olivier Casasnovas, Sylvain Choquet, Cristina Castilla-Llorente, Stéphanie Guidez, Michaël Loschi, Blandine Guffroy, Sylvain Carras, Laurianne Drieu La Rochelle, Mathilde Guillet, Roch Houot
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1573–1585.
https://doi.org/10.1182/bloodadvances.2023011727
Published: 2024
Includes: Supplemental data
Journal Articles

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

Clinical Trials & Observations
Hervé Ghesquières, Fanny Cherblanc, Aurélien Belot, Sophie Micon, Krimo K. Bouabdallah, Cyril Esnault, Luc-Matthieu Fornecker, Katia Thokagevistk, Maxime Bonjour, Fontanet Bijou, Corinne Haioun, Nadine Morineau, Loïc Ysebaert, Gandhi Damaj, Benoit Tessoulin, Stéphanie Guidez, Franck Morschhauser, Catherine Thiéblemont, Adrien Chauchet, Rémy Gressin, Fabrice Jardin, Christophe Fruchart, Gaëlle Labouré, Ludovic Fouillet, Pauline Lionne-Huyghe, Antoine Bonnet, Laure Lebras, Sandy Amorim, Cécile Leyronnas, Gaelle Olivier, Romain Guieze, Roch Houot, Vincent Launay, Bernard Drénou, Olivier Fitoussi, Laurence Detourmignies, Julie Abraham, Carole Soussain, Florence Lachenal, Gian Matteo Pica, Patrick Fogarty, Pascale Cony-Makhoul, Adeline Bernier, Sandra Le Guyader-Peyrou, Alain Monnereau, Frédéric Boissard, Cédric Rossi, Vincent Camus
Journal: Blood Advances
Blood Adv (2024) 8 (2): 296–308.
https://doi.org/10.1182/bloodadvances.2023010798
Published: 2024
Includes: Supplemental data
Journal Articles

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

Clinical Trials & Observations
Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie-Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Rene-Olivier Casasnovas, Magalie Joris, Cristina Castilla-Llorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Franck Morschhauser, Catherine Thieblemont, Roch Houot
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6589–6598.
https://doi.org/10.1182/bloodadvances.2023010624
Published: 2023
Includes: Supplemental data
Journal Articles

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, Jean Marc Schiano De colella, Clement Bailly, Salim Kanoun, Stéphanie Guidez, Emmanuel Gyan, Remy Gressin, Nadine Morineau, Loic Ysebaert, Steven Le Gouill, Herve Tilly, Roch Houot, F. Morschhauser, Guillaume Cartron, Charles Herbaux
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3735–3738.
https://doi.org/10.1182/bloodadvances.2023009911
Published: 2023
Includes: Supplemental data
Journal Articles

Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists

Clinical Trials & Observations
Gaëlle Drillet, Faustine Lhomme, Sophie De Guibert, Guillaume Manson, Roch Houot
Journal: Blood Advances
Blood Adv (2023) 7 (4): 537–540.
https://doi.org/10.1182/bloodadvances.2022008066
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Clinical Trials & Observations
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric Durot, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Ghandi Damaj, Kamel Laribi, Hervé Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Hervé Tilly
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3862–3872.
https://doi.org/10.1182/bloodadvances.2021004778
Published: 2021
Includes: Supplemental data
Journal Articles

Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma

Cédric Ménard, Delphine Rossille, Joelle Dulong, Tien-Tuan Nguyen, Ilenia Papa, Maelle Latour, Nadège Bescher, Isabelle Bezier, Myriam Chouteau, Thierry Fest, Roch Houot, Franck Morschhauser, Karin Tarte
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2063–2074.
https://doi.org/10.1182/bloodadvances.2020003774
Published: 2021
Includes: Supplemental data
Journal Articles

Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study

Clinical Trials & Observations
Marie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, Pierre Feugier, Hervé Maisonneuve, Rene-Olivier Casasnovas, François Lemonnier, Gian Matteo Pica, Roch Houot, Loic Ysebaert, Hervé Tilly, Jean-Claude Eisenmann, Steven Le Gouill, Vincent Ribrag, Pascal Godmer, Sylvie Glaisner, Guillaume Cartron, Luc Xerri, Gilles André Salles, Thierry Fest, Franck Morschhauser
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3217–3223.
https://doi.org/10.1182/bloodadvances.2020001955
Published: 2020
Includes: Supplemental data